Search Results 2701-2710 of 13648 for monoclonal antibody

1. A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies - Mayo Clinic

   - Prior treatment with an anti-TIGIT antibody. - Any active or prior autoimmune disease that required treatment within 3 years of the first dose of study ...

2. Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies - Mayo Clinic

   History of documented allergic reactions or acute hypersensitivity reaction attributed to treatment with antibody therapies in general, or to agents ...

3. Lurbinectedin + Doxorubicin In Leiomyosarcoma - Mayo Clinic

   Participants who have received prior antibody-based therapy (e.g., nivolumab) within 4 weeks or 3 half-lives (whichever is shorter) of cycle 1 day 1.

4. A Phase 1 In Patients With HLA-A*0201+ And WT1+ Recurrent/Metastatic Cancers - Mayo Clinic

   Treatment with any systemic anti-neoplastic therapy, or investigational therapy within the 14 days (or 28 days, for antibody drugs), before the first dose of ...

5. INCB161734 For Advanced Or Metastatic Solid Tumors With KRAS G12D Mutation - Mayo Clinic

   Known HIV infection (positive for HIV 1/2 antibodies). Medications. Treatment with prohibited medication as described in Section 6.7.3 within 5 half-lives or ...

6. Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004) - Mayo Clinic

   * Received prior treatment with a trophoblast cell-surface antigen 2 (TROP2)-targeted antibody-drug conjugate (ADC). * Received prior treatment with a ...

7. Lowering Rejection Risk in Organ Transplants (pkg) - Mayo Clinic News Network

   Among the more than 120,000 Americans waiting for an organ transplant, thousands are told their likelihood of rejection is too high to take the risk.

8. AZD5305 Vs Placebo In Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents - Mayo Clinic

   Participants positive for HCV antibody are eligible only if polymerase chain reaction is negative for HCV RNA;. NOTE: Inclusion of this group of participants ...

9. Leukemia - Doctors and departments - Mayo Clinic

   Bispecific antibody therapy · Bone marrow biopsy · Bone marrow transplant · Cancer treatment · Chemotherapy · Radiation therapy. Show more associated procedures ...

10. Leukemia - Doctors and departments - Mayo Clinic

    Bispecific antibody therapy · Bone marrow biopsy · Bone marrow transplant · Cancer treatment · Chemotherapy · Radiation therapy. Show more associated procedures ...